CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionGross margin is 16.6%, lower than 95% of its Medical Devices peers (median 61%)
- FinancialsAltman Z-Score 2.55: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.92BCNY285.31M · vs all stocks (USD)
Revenue (TTM)
747.81MCNY111.07M · vs all stocks (USD)
Profit Margin
-0.65%vs Medical Devices peers
Beta
0.7090xvs all stocks
52-Week Change
-16.83%vs all stocks
Market Capitalization
1.92BCNY285.31M · vs all stocks (USD)
Enterprise Value
1.45BCNY215.01M · vs all stocks (USD)
Price to Sales (TTM)
2.63xvs Medical Devices peers
Price to Book (MRQ)
1.54xvs Medical Devices peers
Enterprise to Revenue
1.94xvs Medical Devices peers
Enterprise to EBITDA
-181.02xvs Medical Devices peers
Gross Margin
16.56%vs Medical Devices peers
Profit Margin
-0.65%vs Medical Devices peers
Operating Margin
-2.92%vs Medical Devices peers
Return on Assets (TTM)
-0.50%vs Medical Devices peers
Return on Equity (TTM)
-0.67%vs Medical Devices peers
Revenue (TTM)
747.81MCNY111.07M · vs all stocks (USD)
Revenue per Share (TTM)
7.79CNYUpdated Aug 20, 2026Quarterly Revenue Growth
107.90%vs Medical Devices peers
Gross Profit (TTM)
158.08MCNY23.48M · vs all stocks (USD)
EBITDA (TTM)
80.87MCNY12.01M · vs all stocks (USD)
Net Income (TTM)
-4.89MCNY-725.84K · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-80.71%vs Medical Devices peers
Operating Cash Flow (TTM)
-17.34MCNY-2.57M · vs all stocks (USD)
Payout Ratio
698.71%vs Medical Devices peers
Minority Interest (Equity)
-1.53MCNYFY2025 · Dec 31, 2025Revenue
721.61MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
558.12MCNYFY2025 · Dec 31, 2025Gross Profit
163.50MCNYFY2025 · Dec 31, 2025Operating Income
61.17MCNY9.09M · vs all stocks (USD)
Pre-tax Income
-8.70MCNYFY2025 · Dec 31, 2025Income Tax Expense
-3.52MCNYFY2025 · Dec 31, 2025Net Income
-5.18MCNYFY2025 · Dec 31, 2025EBIT
-2.35MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
80.87MCNYFY2025 · Dec 31, 2025Research & Development
25.99MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
33.36MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.40MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.30MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
6.35MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0274CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0274CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
96.54MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
96.54MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-5.18MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
2.53MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-225.55MCNYFY2025 · Dec 31, 2025Free Cash Flow
-249.65MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
181.61MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-5.18MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.97MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-130.78MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-91.56MCNYFY2025 · Dec 31, 2025Capital Expenditures
-24.09MCNYFY2025 · Dec 31, 2025Purchase of Investments
-659.25MCNYFY2025 · Dec 31, 2025Sale of Investments
326.00MCNYFY2025 · Dec 31, 2025Other Investing Activity
3.63MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-353.72MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
256.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-171.50MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-18.66MCNYFY2025 · Dec 31, 2025Other Financing Charges
-95.27MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-29.43MCNYFY2025 · Dec 31, 2025Shares Outstanding
100.00MSharesUpdated Aug 20, 2026Float Shares
50.97MSharesUpdated Aug 20, 2026% Held by Insiders
55.52%vs all stocks
% Held by Institutions
2.42%vs all stocks
Total Cash (MRQ)
706.01MCNY104.86M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.35CNYUpdated Aug 20, 2026Total Debt (MRQ)
274.47MCNY40.76M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2244xvs Medical Devices peers
Current Ratio (MRQ)
2.44xvs Medical Devices peers
Book Value per Share (MRQ)
12.76CNYUpdated Aug 20, 2026Total Assets
2.06BCNY306.62M · vs all stocks (USD)
Total Current Assets
1.79BCNYFY2025 · Dec 31, 2025Total Liabilities
841.14MCNYFY2025 · Dec 31, 2025Total Non-current Assets
277.58MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
73.43MCNYFY2025 · Dec 31, 2025Total Current Liabilities
767.71MCNYFY2025 · Dec 31, 2025Cash
184.20MCNYFY2025 · Dec 31, 2025Cash Equivalents
514.15MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
698.35MCNYFY2025 · Dec 31, 2025Accounts Receivable
759.83MCNYFY2025 · Dec 31, 2025Inventory
280.78MCNYFY2025 · Dec 31, 2025Accounts Payable
323.07MCNYFY2025 · Dec 31, 2025Short-term Debt
205.53MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.01MCNYFY2025 · Dec 31, 2025Long-term Debt
42.46MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
17.22MCNYFY2025 · Dec 31, 2025Common Stock (Book)
100.00MCNYFY2025 · Dec 31, 2025Retained Earnings
353.19MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.22BCNY181.69M · vs all stocks (USD)
Treasury Stock
73.14MCNYFY2025 · Dec 31, 202552-Week Low
15.16CNYUpdated Aug 20, 202652-Week High
27.40CNYUpdated Aug 20, 202652-Week Change
-16.83%vs all stocks
Beta
0.7090xvs all stocks
50-Day MA
18.29CNYUpdated Aug 20, 2026200-Day MA
21.90CNYUpdated Aug 20, 2026Avg 10-Day Volume
1.54MSharesUpdated Aug 20, 2026Avg 30-Day Volume
1.64MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
-0.0500CNYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 16.6%, lower than 95% of its Medical Devices peers (median 61%)Significant
Gross margin: 0.17Industry median: 0.61Industry P5: 0.28Peers compared: 102
Financial Health
Altman Z-Score 2.55: grey zoneSignificant
Altman Z-Score: 2.55
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanghai Hile Bio-Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Dirui Industrial Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lineage Cell Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Inventage Lab Inc.
Tier 1ProductionApproval-Gated PipelineRule
CytoDyn Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Cutia Therapeutics Limited
Tier 1ProductionApproval-Gated PipelineRuleRisk
Jiangsu GDK Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Alx Oncology Holdings Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Cresco Labs Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Curocell Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking